http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050042490-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-01014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
filingDate 2003-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cd78ed0a2ad9385ec43332b36720156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94152e18c503dee0cdecd2c4e4eb74d
publicationDate 2005-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20050042490-A
titleOfInvention Process for producing optically active erythro 3-cyclohexylserines
abstract In the present invention, N-acyl of DL-erythro-3-substituted serine represented by the following general formula (1) is subjected to subsidiary hydrolysis by L-aminoacylase or D-aminoacylase, and in the case of L-acylase The present invention relates to a method of obtaining an unreacted N-acyl-D-erythro-3-substituted serine and, in the case of D-aminoacylase, a hydrolyzed D-erythro-3-substituted serine. Is useful as an intermediate such as a drug, for example, a drug known to be useful as an anti-HIV drug (WO01 / 40227):n n n n n n n n Wheren n n R 1 represents an alkanoyl group having 1 to 10 carbon atoms, a benzoyl group, an alkanoyl group having 1 to 5 carbon atoms substituted by a halogen atom or a benzoyl group substituted by a halogen atom,n n n R 2 means a phenyl group or a cyclohexyl group.
priorityDate 2002-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450577607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12003069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426169444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454390493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426025815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449607352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154439305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4275592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422148627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425504968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18508370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18320909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457270017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452445187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID306
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID83263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24942486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69603039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432989227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422014546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451697825
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID83263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410576207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18799167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12314153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131723094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410524066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID672407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10080373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90495

Total number of triples: 72.